CLINICAL_TRIALS
trial_result
· 2023-08-09
Clinical Trial Update: Selegiline to Zelapar Switch Study in Parkinson Disease Patients [Phase 4]
Summary
Phase 4 clinical trial update evaluating a switch from selegiline to Zelapar in Parkinson's disease patients has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Baylor College of Medicine | Conditions: Parkinson's Disease | Phase 4 | Status: COMPLETED | Results posted: 2023-08-09